N-(1-adamantyl)-2-(4-pyridin-2-ylpiperazin-1-yl)acetamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: N-(1-adamantyl)-2-(4-pyridin-2-ylpiperazin-1-yl)acetamide
• 化学式: C₂₁H₃₀N₄O
• 分子量: 354.495
• InChiKey: AKGNYVCZUMSMOX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  26
• 可旋转键数：
  4
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  48.5
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• NOVEL COMPOUNDS OF SUBSTITUTED AND UNSUBTITUTED ADAMANTYL AMIDES
  申请人：Cheng Hengmiao

  公开号：US20090093463A1

  公开（公告）日：2009-04-09

  The present invention relates to compounds with the formula (I) or a pharmaceutically acceptable salt thereof: The invention also relates to pharmaceutical compositions comprising the compounds of formula (I) and methods of treating a condition that is mediated by the modulation of 11-β-hsd-1, the method comprising administering to a mammal an effective amount of a compound of formula (I).

  本发明涉及公式(I)的化合物或其药学上可接受的盐：该发明还涉及包含公式(I)化合物的制药组合物，以及治疗通过调节11-β-hsd-1介导的疾病的方法，该方法包括向哺乳动物投与公式(I)化合物的有效量。
• NOVEL COMPOUNDS OF SUBSTITUTED AND UNSUBSTITUTED ADAMANTYL AMIDES
  申请人：Pfizer, Inc.

  公开号：EP1812407A2

  公开（公告）日：2007-08-01
• [EN] NOVEL COMPOUNDS OF SUBSTITUTED AND UNSUBSTITUTED ADAMANTYL AMIDES<br/>[FR] NOUVEAUX COMPOSES D'ADAMANTYL AMIDES SUBSTITUES OU NON
  申请人：PFIZER

  公开号：WO2006048750A2

  公开（公告）日：2006-05-11

  [EN] The present invention relates to compounds with the formula (I) or a pharmaceutically acceptable salt thereof: The invention also relates to pharmaceutical compositions comprising the compounds of formula (I) and methods of treating a condition that is mediated by the modulation of 11-ß-hsd-1, the method comprising administering to a mammal an effective amount of a compound of formula (I).
  [FR] L'invention porte sur des composés de formule (I) et leurs sels pharmacocompatibles, ainsi que sur des procédés de traitement d'états médiés par la modulation du 11-ß-hsd-1, consistant à administrer à un mammifère une quantité efficace du composé de formule (1).